Used as a key intermediate in the synthesis of adenosine receptor antagonists, particularly for A2A and A1 subtypes. It plays an important role in pharmaceutical research targeting neurological disorders such as Parkinson’s disease and inflammation-related conditions. The compound's structure allows for selective modification, making it valuable in developing potent and selective small-molecule inhibitors. It is also employed in radiolabeling studies to investigate receptor binding and distribution in tissues.